Cargando…

Acceptability and Effectiveness of Artificial Intelligence Therapy for Anxiety and Depression (Youper): Longitudinal Observational Study

BACKGROUND: Youper is a widely used, commercially available mobile app that uses artificial intelligence therapy for the treatment of anxiety and depression. OBJECTIVE: Our study examined the acceptability and effectiveness of Youper. Further, we tested the cumulative regulation hypothesis, which po...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehta, Ashish, Niles, Andrea Nicole, Vargas, Jose Hamilton, Marafon, Thiago, Couto, Diego Dotta, Gross, James Jonathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423345/
https://www.ncbi.nlm.nih.gov/pubmed/34155984
http://dx.doi.org/10.2196/26771
_version_ 1783749449510551552
author Mehta, Ashish
Niles, Andrea Nicole
Vargas, Jose Hamilton
Marafon, Thiago
Couto, Diego Dotta
Gross, James Jonathan
author_facet Mehta, Ashish
Niles, Andrea Nicole
Vargas, Jose Hamilton
Marafon, Thiago
Couto, Diego Dotta
Gross, James Jonathan
author_sort Mehta, Ashish
collection PubMed
description BACKGROUND: Youper is a widely used, commercially available mobile app that uses artificial intelligence therapy for the treatment of anxiety and depression. OBJECTIVE: Our study examined the acceptability and effectiveness of Youper. Further, we tested the cumulative regulation hypothesis, which posits that cumulative emotion regulation successes with repeated intervention engagement will predict longer-term anxiety and depression symptom reduction. METHODS: We examined data from paying Youper users (N=4517) who allowed their data to be used for research. To characterize the acceptability of Youper, we asked users to rate the app on a 5-star scale and measured retention statistics for users’ first 4 weeks of subscription. To examine effectiveness, we examined longitudinal measures of anxiety and depression symptoms. To test the cumulative regulation hypothesis, we used the proportion of successful emotion regulation attempts to predict symptom reduction. RESULTS: Youper users rated the app highly (mean 4.36 stars, SD 0.84), and 42.66% (1927/4517) of users were retained by week 4. Symptoms decreased in the first 2 weeks of app use (anxiety: d=0.57; depression: d=0.46). Anxiety improvements were maintained in the subsequent 2 weeks, but depression symptoms increased slightly with a very small effect size (d=0.05). A higher proportion of successful emotion regulation attempts significantly predicted greater anxiety and depression symptom reduction. CONCLUSIONS: Youper is a low-cost, completely self-guided treatment that is accessible to users who may not otherwise access mental health care. Our findings demonstrate the acceptability and effectiveness of Youper as a treatment for anxiety and depression symptoms and support continued study of Youper in a randomized clinical trial.
format Online
Article
Text
id pubmed-8423345
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher JMIR Publications
record_format MEDLINE/PubMed
spelling pubmed-84233452021-10-18 Acceptability and Effectiveness of Artificial Intelligence Therapy for Anxiety and Depression (Youper): Longitudinal Observational Study Mehta, Ashish Niles, Andrea Nicole Vargas, Jose Hamilton Marafon, Thiago Couto, Diego Dotta Gross, James Jonathan J Med Internet Res Original Paper BACKGROUND: Youper is a widely used, commercially available mobile app that uses artificial intelligence therapy for the treatment of anxiety and depression. OBJECTIVE: Our study examined the acceptability and effectiveness of Youper. Further, we tested the cumulative regulation hypothesis, which posits that cumulative emotion regulation successes with repeated intervention engagement will predict longer-term anxiety and depression symptom reduction. METHODS: We examined data from paying Youper users (N=4517) who allowed their data to be used for research. To characterize the acceptability of Youper, we asked users to rate the app on a 5-star scale and measured retention statistics for users’ first 4 weeks of subscription. To examine effectiveness, we examined longitudinal measures of anxiety and depression symptoms. To test the cumulative regulation hypothesis, we used the proportion of successful emotion regulation attempts to predict symptom reduction. RESULTS: Youper users rated the app highly (mean 4.36 stars, SD 0.84), and 42.66% (1927/4517) of users were retained by week 4. Symptoms decreased in the first 2 weeks of app use (anxiety: d=0.57; depression: d=0.46). Anxiety improvements were maintained in the subsequent 2 weeks, but depression symptoms increased slightly with a very small effect size (d=0.05). A higher proportion of successful emotion regulation attempts significantly predicted greater anxiety and depression symptom reduction. CONCLUSIONS: Youper is a low-cost, completely self-guided treatment that is accessible to users who may not otherwise access mental health care. Our findings demonstrate the acceptability and effectiveness of Youper as a treatment for anxiety and depression symptoms and support continued study of Youper in a randomized clinical trial. JMIR Publications 2021-06-22 /pmc/articles/PMC8423345/ /pubmed/34155984 http://dx.doi.org/10.2196/26771 Text en ©Ashish Mehta, Andrea Nicole Niles, Jose Hamilton Vargas, Thiago Marafon, Diego Dotta Couto, James Jonathan Gross. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 22.06.2021. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in the Journal of Medical Internet Research, is properly cited. The complete bibliographic information, a link to the original publication on https://www.jmir.org/, as well as this copyright and license information must be included.
spellingShingle Original Paper
Mehta, Ashish
Niles, Andrea Nicole
Vargas, Jose Hamilton
Marafon, Thiago
Couto, Diego Dotta
Gross, James Jonathan
Acceptability and Effectiveness of Artificial Intelligence Therapy for Anxiety and Depression (Youper): Longitudinal Observational Study
title Acceptability and Effectiveness of Artificial Intelligence Therapy for Anxiety and Depression (Youper): Longitudinal Observational Study
title_full Acceptability and Effectiveness of Artificial Intelligence Therapy for Anxiety and Depression (Youper): Longitudinal Observational Study
title_fullStr Acceptability and Effectiveness of Artificial Intelligence Therapy for Anxiety and Depression (Youper): Longitudinal Observational Study
title_full_unstemmed Acceptability and Effectiveness of Artificial Intelligence Therapy for Anxiety and Depression (Youper): Longitudinal Observational Study
title_short Acceptability and Effectiveness of Artificial Intelligence Therapy for Anxiety and Depression (Youper): Longitudinal Observational Study
title_sort acceptability and effectiveness of artificial intelligence therapy for anxiety and depression (youper): longitudinal observational study
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423345/
https://www.ncbi.nlm.nih.gov/pubmed/34155984
http://dx.doi.org/10.2196/26771
work_keys_str_mv AT mehtaashish acceptabilityandeffectivenessofartificialintelligencetherapyforanxietyanddepressionyouperlongitudinalobservationalstudy
AT nilesandreanicole acceptabilityandeffectivenessofartificialintelligencetherapyforanxietyanddepressionyouperlongitudinalobservationalstudy
AT vargasjosehamilton acceptabilityandeffectivenessofartificialintelligencetherapyforanxietyanddepressionyouperlongitudinalobservationalstudy
AT marafonthiago acceptabilityandeffectivenessofartificialintelligencetherapyforanxietyanddepressionyouperlongitudinalobservationalstudy
AT coutodiegodotta acceptabilityandeffectivenessofartificialintelligencetherapyforanxietyanddepressionyouperlongitudinalobservationalstudy
AT grossjamesjonathan acceptabilityandeffectivenessofartificialintelligencetherapyforanxietyanddepressionyouperlongitudinalobservationalstudy